---
title: "A roadmap to using historical controls in clinical trials"
source: new
date: "2021-04-28"
categories:
- Recommendation
tags:
- Graphical display
output: html_document
page_update: complete
---

![](http://www.pmean.com/new-images/21/roadmap-historical-controls-01.png)

<div class="notes">

More and more new drug applications are relying on historical controls, but this must be done carefully. This paper outlines the reasons why you might want to use historical controls versus concurrent controls, alternative analysis methods, and how to minimize the biases associated with historical controls.. 

Mercedeh Ghadessi, Rui Tang, Joey Zhou, Rong Liu, Chenkun Wang, Kiichiro Toyoizumi, Chaoqun Mei, Lixia Zhang, C. Q. Deng, Robert A. Beckman. A roadmap to using historical controls in clinical trials â€“ by Drug Information Association Adaptive Design Scientific Working Group (DIA-ADSWG). Orphanet Journal of Rare Diseases, 15, 69 (2020). Available in [html format][gha1] or [pdf format][gha2].

[gha1]: https://doi.org/10.1186/s13023-020-1332-x
[gha2]: https://ojrd.biomedcentral.com/track/pdf/10.1186/s13023-020-1332-x.pdf

</div>
